(VEA) Vanguard FTSE Developed - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US9219438580
VEA: Stocks, Canada, Europe, Pacific, Large, Mid, Small Cap
The Vanguard FTSE Developed Markets Index Fund ETF Shares is a passively managed exchange-traded fund that seeks to replicate the performance of the FTSE Developed All Cap ex U.S. Index. This index comprises approximately 3,957 common stocks of companies across various market capitalizations in Canada, Europe, and the Pacific region, providing broad diversification and exposure to developed international markets.
The funds investment strategy is centered around holding a representative sample of the securities in the underlying index, with each stock weighted according to its market capitalization. This approach allows the fund to track the indexs performance closely, minimizing tracking error and providing investors with a low-cost means of accessing international equities.
With a substantial asset base, the fund benefits from economies of scale, which can help reduce costs for investors. The funds diversification across geographies and market capitalizations can also help mitigate risk, making it a potentially attractive option for investors seeking to broaden their investment portfolios.
Analyzing the funds recent price action and technical indicators, we observe that the current price is near its 52-week high, with a relatively stable ATR indicating moderate volatility. The SMA20, SMA50, and SMA200 are all trending upwards, suggesting a positive medium- to long-term outlook. Based on this technical analysis, we can forecast that the funds price is likely to continue its upward trajectory, potentially reaching new highs in the near term.
Considering the funds fundamental characteristics, such as its large asset base and low-cost structure, we can expect the fund to continue to attract investor flows, potentially driving further growth in its assets under management. Combining this with the technical analysis, our forecast suggests that VEA may reach a price of $58.00 within the next 6-12 months, representing a potential upside of around 4.3% from current levels.
Additional Sources for VEA ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
VEA ETF Overview
Market Cap in USD | 162,180m |
Category | Foreign Large Blend |
TER | 0.05% |
IPO / Inception | 2007-07-20 |
VEA ETF Ratings
Growth Rating | 59.9 |
Fundamental | - |
Dividend Rating | 53.2 |
Rel. Strength | 2.57 |
Analysts | - |
Fair Price Momentum | 54.69 USD |
Fair Price DCF | - |
VEA Dividends
Dividend Yield 12m | 2.06% |
Yield on Cost 5y | 3.30% |
Annual Growth 5y | 10.71% |
Payout Consistency | 93.4% |
Payout Ratio | % |
VEA Growth Ratios
Growth Correlation 3m | 95.6% |
Growth Correlation 12m | 57.6% |
Growth Correlation 5y | 64.7% |
CAGR 5y | 11.29% |
CAGR/Max DD 5y | 0.38 |
Sharpe Ratio 12m | 1.33 |
Alpha | 7.01 |
Beta | 0.761 |
Volatility | 13.70% |
Current Volume | 11044.8k |
Average Volume 20d | 13118.2k |
As of June 29, 2025, the stock is trading at USD 56.83 with a total of 11,044,778 shares traded.
Over the past week, the price has changed by +3.33%, over one month by +2.67%, over three months by +10.53% and over the past year by +18.62%.
Partly, yes. Based on ValueRay´s Analyses, Vanguard FTSE Developed (NYSE ARCA:VEA) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.93 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VEA is around 54.69 USD . This means that VEA is currently overvalued and has a potential downside of -3.77%.
Vanguard FTSE Developed has no consensus analysts rating.
According to our own proprietary Forecast Model, VEA Vanguard FTSE Developed will be worth about 62.6 in June 2026. The stock is currently trading at 56.83. This means that the stock has a potential upside of +10.12%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 62.6 | 10.1% |